Cargando…
TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4
Objective: Trimethylamine-N-oxide (TMAO) was found to play crucial roles in vascular endothelial function. However, the exact molecular mechanisms are not yet entirely clear. Recently, we found that exosomes (Exos) isolated from TMAO-treated hepatocytes (TMAO-Exos) contained a distinctive profile of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841965/ https://www.ncbi.nlm.nih.gov/pubmed/35174166 http://dx.doi.org/10.3389/fcell.2021.804049 |
_version_ | 1784650956283052032 |
---|---|
author | Liu, Xiang Shao, Yijia Tu, Jiazichao Sun, Jiapan Dong, Bing Wang, Zhichao Zhou, Jianrong Chen, Long Tao, Jun Chen, Jimei |
author_facet | Liu, Xiang Shao, Yijia Tu, Jiazichao Sun, Jiapan Dong, Bing Wang, Zhichao Zhou, Jianrong Chen, Long Tao, Jun Chen, Jimei |
author_sort | Liu, Xiang |
collection | PubMed |
description | Objective: Trimethylamine-N-oxide (TMAO) was found to play crucial roles in vascular endothelial function. However, the exact molecular mechanisms are not yet entirely clear. Recently, we found that exosomes (Exos) isolated from TMAO-treated hepatocytes (TMAO-Exos) contained a distinctive profile of miRNAs compared to those from the TMAO-free group (Control-Exos). Furthermore, TMAO-Exos could notably promote inflammation, damage vascular endothelial cells (VECs), and impair endothelium-dependent vasodilation. This study aimed to further evaluate the effects of TMAO-Exos on VECs and explore the underlying mechanisms. Methods: Exos were isolated from the hepatocyte culture supernatant with or without TMAO, using differential centrifugation. Then, VECs were treated with these Exos for 48 h and subjected to RNA-sequencing for detecting the changes of alternative polyadenylation (APA) and mRNA. After validation by qPCR and western blotting, the recombinant viruses were used to mediate the overexpression of C-X-C motif chemokine receptor 4 (CXCR4). The in vitro VEC function was evaluated by cell migration and tube formation, and in vivo angiogenesis was investigated in hindlimb ischemia models. Results: Exos released from hepatocytes were differentially regulated by TMAO; both could be taken up by VECs; and furthermore, TMAO-Exos significantly reduced cell migration and tube formation in vitro and impaired perfusion recovery and angiogenesis after hindlimb ischemia, by down-regulating the CXCR4 expression. However, TMAO-Exos failed to regulate the splicing events, at least in this experimental setting, which suggested that TMAO-Exos may affect CXCR4 expression via an APA-independent manner. Conclusions: Our findings revealed a novel indirect mechanism by which TMAO impaired endothelial function through stimulating hepatocytes to produce Exos that possessed distinctive activity. The crosstalk between the liver and vascular endothelial mediated by these Exos may offer a new target for restraining the harmful effects induced by TMAO. |
format | Online Article Text |
id | pubmed-8841965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88419652022-02-15 TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4 Liu, Xiang Shao, Yijia Tu, Jiazichao Sun, Jiapan Dong, Bing Wang, Zhichao Zhou, Jianrong Chen, Long Tao, Jun Chen, Jimei Front Cell Dev Biol Cell and Developmental Biology Objective: Trimethylamine-N-oxide (TMAO) was found to play crucial roles in vascular endothelial function. However, the exact molecular mechanisms are not yet entirely clear. Recently, we found that exosomes (Exos) isolated from TMAO-treated hepatocytes (TMAO-Exos) contained a distinctive profile of miRNAs compared to those from the TMAO-free group (Control-Exos). Furthermore, TMAO-Exos could notably promote inflammation, damage vascular endothelial cells (VECs), and impair endothelium-dependent vasodilation. This study aimed to further evaluate the effects of TMAO-Exos on VECs and explore the underlying mechanisms. Methods: Exos were isolated from the hepatocyte culture supernatant with or without TMAO, using differential centrifugation. Then, VECs were treated with these Exos for 48 h and subjected to RNA-sequencing for detecting the changes of alternative polyadenylation (APA) and mRNA. After validation by qPCR and western blotting, the recombinant viruses were used to mediate the overexpression of C-X-C motif chemokine receptor 4 (CXCR4). The in vitro VEC function was evaluated by cell migration and tube formation, and in vivo angiogenesis was investigated in hindlimb ischemia models. Results: Exos released from hepatocytes were differentially regulated by TMAO; both could be taken up by VECs; and furthermore, TMAO-Exos significantly reduced cell migration and tube formation in vitro and impaired perfusion recovery and angiogenesis after hindlimb ischemia, by down-regulating the CXCR4 expression. However, TMAO-Exos failed to regulate the splicing events, at least in this experimental setting, which suggested that TMAO-Exos may affect CXCR4 expression via an APA-independent manner. Conclusions: Our findings revealed a novel indirect mechanism by which TMAO impaired endothelial function through stimulating hepatocytes to produce Exos that possessed distinctive activity. The crosstalk between the liver and vascular endothelial mediated by these Exos may offer a new target for restraining the harmful effects induced by TMAO. Frontiers Media S.A. 2022-01-31 /pmc/articles/PMC8841965/ /pubmed/35174166 http://dx.doi.org/10.3389/fcell.2021.804049 Text en Copyright © 2022 Liu, Shao, Tu, Sun, Dong, Wang, Zhou, Chen, Tao and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Liu, Xiang Shao, Yijia Tu, Jiazichao Sun, Jiapan Dong, Bing Wang, Zhichao Zhou, Jianrong Chen, Long Tao, Jun Chen, Jimei TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4 |
title | TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4 |
title_full | TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4 |
title_fullStr | TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4 |
title_full_unstemmed | TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4 |
title_short | TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4 |
title_sort | tmao-activated hepatocyte-derived exosomes impair angiogenesis via repressing cxcr4 |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841965/ https://www.ncbi.nlm.nih.gov/pubmed/35174166 http://dx.doi.org/10.3389/fcell.2021.804049 |
work_keys_str_mv | AT liuxiang tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT shaoyijia tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT tujiazichao tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT sunjiapan tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT dongbing tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT wangzhichao tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT zhoujianrong tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT chenlong tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT taojun tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 AT chenjimei tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4 |